Evaluating congestion in patients with acute heart failure at discharge
Official title: Acute Heart Failure - COngestion Discharge Evaluation. Évaluation de la Congestion à la Sortie d'Hospitalisation Pour Insuffisance Cardiaque aiguë.
Run by Central Hospital, Nancy, France · NCT04332692 · Data updated 2026-11-12
This study is testing new ways to check for fluid buildup in the lungs of patients with acute heart failure when they leave the hospital to see if it can help them recover better.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 110 (estimated) |
| Sponsor | Central Hospital, Nancy, France Academic / other |
| Locations | 1 site (Vandœuvre-lès-Nancy) |
| Status | Recruiting |
| Started | July 15, 2020 |
| Main results expected | August 20, 2026 |
| Study ends | May 20, 2028 |
| Registry record updated | June 5, 2023 |
| Trial ID | NCT04332692 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 and older who are hospitalized for acute heart failure and are clinically ready for discharge.
✕Probably not a fit
Patients with severe comorbidities, those on dialysis, or individuals with significant pulmonary pathology may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study focuses on patients hospitalized for acute heart failure and aims to improve discharge outcomes by assessing congestion using various methods, including clinical examinations and advanced imaging techniques. The goal is to adapt treatment based on a standardized evaluation of lung congestion, which is currently lacking in clinical practice. By utilizing Doppler ultrasounds and biological assessments, the study seeks to establish a multimodal approach to better manage acute heart failure at discharge.
Why it matters
Potential benefit: If successful, this study could significantly reduce the risk of death and re-hospitalization for patients with acute heart failure.
How similar studies have gone: While the approach of using multimodal congestion assessment is promising, it is not widely tested, making this study a potentially novel contribution to the field.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients hospitalised for acute heart failure. * Patients considered clinically discharging from hospitalisation for acute heart failure. * Age ≥18 years * Patients having received complete information regarding the study design and having signed their informed consent form. * Patient affiliated to or beneficiary of a social security scheme. Exclusion Criteria: * Comorbidity for which the life expectancy is ≤ 3 months * Dialysis patient (peritoneal dialysis or hemodialysis) or patients with glomerular filtration rate \<15 ml/min/m2 at inclusion. * History of lobectomy or pneumonectomy lung surgery * Severe pulmonary or pleural pathology preventing reliable acquisition of lung ultrasound images: severe emphysema, chronic pleurisy, pulmonary fibrosis, etc. * Pregnant woman, parturient or nursing mother * Adult person subject to a legal protection measure (guardianship, curatorship, safeguard of justice) * Adult person who is unable to give consent * Person deprived of liberty by a judicial or administrative decision, * Person subject to psychiatric care pursuant to Articles L. 3212-1 and L. 3213-1 of the Public Health Code.
Where it's running
-
CHRU de Nancy
Vandœuvre-lès-Nancy, France Recruiting
Study contacts
- Principal investigator: Nicolas GIRERD, MD,PhD — CHRU of Nancy
- Study coordinator: Nicolas GIRERD, MD,PhD
- Email: n.girerd@chru-nancy.fr
- Phone: + 33 3 83 15 73 22
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Infusion of furosemide to see if a loading infusion helps remove fluid better in acute heart failure
This study tests whether giving furosemide as a continuous infusion with a loading dose is better at removing excess fluid than giving it as bolus injections in adults with acute heart failure.
-
Characterizing phenotypes of acute heart failure
This project will try to see if heart function measures, imaging features (radiomics), and blood biomarkers can predict outcomes for adults hospitalized with acute heart failure, including cardiogenic shock.
-
Early finerenone treatment for hospitalized adults with acute heart failure and LVEF ≥40%
This trial will test whether starting finerenone early during hospitalization helps adults with acute heart failure who have a left ventricular ejection fraction of 40% or higher.
-
Intensive GDMT optimization for women after heart failure hospitalization
This study tests whether rapidly increasing and closely monitoring heart failure meds in women after hospitalization can reduce death or readmission within a year.
-
Using intra‑abdominal pressure and bedside ultrasound to guide decongestive treatment in heart failure
This trial will test whether using bladder pressure (intra‑abdominal pressure) measurements together with bedside ultrasound to guide IV loop diuretics helps people hospitalized with acute heart failure get rid of excess fluid more effectively than usual care.
-
Investigating heart issues in COPD patients during hospital stays
This study is trying to see if sudden worsening of COPD can cause heart problems in hospitalized patients and how it affects their recovery.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.